Previous Close | 0.8270 |
Open | 0.8200 |
Bid | 0.8553 x 100 |
Ask | 0.8939 x 200 |
Day's Range | 0.8000 - 0.8892 |
52 Week Range | 0.6100 - 9.3720 |
Volume | |
Avg. Volume | 1,220,675 |
Market Cap | 20.927M |
Beta (5Y Monthly) | 0.81 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Though early-stage results on Vincerx's (VINC) experimental drug did show signs of anti-tumor activity, the share price drops as some analysts stated that the results were below expectations.
Comparing Vincerx Pharma's Performance Against Analyst Estimates
In this piece, we will take a look at the 12 most profitable biotech stocks to invest in. If you want to skip our overview of the global biotechnology industry and the latest trends, then you can take a look at the 5 Most Profitable Biotech Stocks To Invest In. Biotechnology is the riskiest and […]